Effects of chromatin function inhibitors on yeast whole cells and spheroplasts

ATLA Alternatives to Laboratory Animals

Volumn 27, Issue 6, 1999, Pages 951-956

  Tiligada, Ekaterini ^a   Stavrinidis, Elias ^a   Manolis, Christos ^a   Delitheos, Andreas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chromatin function inhibitors; Spheroplasts; Yeast

Indexed keywords

ETOPOSIDE; PACLITAXEL; VERAPAMIL; VINBLASTINE;

ARTICLE; CELL GROWTH; CELL WALL; CHROMATIN; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; EXPERIMENTAL MODEL; GROWTH CURVE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SPHEROPLAST; YEAST CELL;

EUKARYOTA; SACCHAROMYCES CEREVISIAE;

EID: 0033376536     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119299902700610     Document Type: Article

References (25)

1. Gause, G.F. & Laiko, A.V. (1978). Yeast mutants with distorted cell membranes as a detection system for antitumor antibiotics. Antibiotics and Chemotherapy 23, 21-25.
2. White, R.J. (1982). Microbiological models as screening tools for anticancer agents: potentials and limitations. Annual Review of Microbiology 36, 415-433.
3. Botstein, D. & Fink, G.R. (1988). Yeast: an experimental organism for modern biology. Science 240, 1439-1443.
4. Herskowitz, I. (1988). Life cycle of the budding yeast Saccharomyces cerevisiae. Microbiological Reviews 52, 536-553.
5. Hartwell, L.H. (1992). Role of yeast in cancer research. Cancer 69, 2615-2621.
6. Deutch, C.E. & Parry, J.M. (1974). Spheroplast formation in yeast during the transition from exponential phase to stationary phase. Journal of General Microbiology 80, 259-268.
7. Nitiss, J. & Wang, J.C. (1988). DNA topoisomerase-targeting antitumour drugs can be studied in yeast. Proceedings of the National Academy of Sciences, USA 85, 7501-7505.
8. Tiligada, E. & Delitheos, A. (1993). Involvement of potassium ions in the action of various antineoplastic drugs on the growth of Saccharomyces cerevisiae. Letters in Applied Microbiology 16, 251-253.
9. Delitheos, A., Tiligada, E., Stavrinidis, E., Manolis, C. & Vovou, I. (1995). Effect of antineoplastic drugs on Saccharomyces cerevisiae under stress conditions. Anticancer Research 15, 2921.
10. Tiligada, E., Giannakakou, P., Karavokyros, I. & Delitheos, A. (1996). Effect of calcium channel blockers on the action of various antitumour agents in the yeast Saccharomyces cerevisiae. Journal of Applied Bacteriology 81, 481-485.
11. Raymond, M., Ruetz, S., Thomas, D.Y. & Gros, P. (1994). Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520. Molecular and Cellular Biology 14, 277-286.
12. Hutchison, H.T. & Hartwell, L.H. (1967). Macromolecule synthesis in yeast spheroplasts. Journal of Bacteriology 94, 1697-1705.
13. Delitheos, A., Karavokyros, I. & Tiligada, E. (1995). Response of Saccharomyces cerevisiae strains to antineoplastic agents. Journal of Applied Bacteriology 79, 379-383.
14. American Type Culture Collection (1987). Catalogue of Fungi Yeast, 325pp. Rockville, MD, USA: ATCC.
15. American Type Culture Collection (1995). ATCC Yeast, 108pp. Rockville, MD, USA: ATCC.
16. Scott, J.H. & Schekman, R. (1980). Lyticase: endoglucanase and protease activities that act together in yeast cell lysis. Journal of Bacteriology 142, 414-423.
17. Henschke, P.A., Thomas, D.S., Rose, A.H. & Veazey, R. (1983). Association of intracellular low-density vesicles with plasma membranes from Saccharomyces cerevisiae NCYC 366. Journal of General Microbiology 129, 2927-2938.
18. Lee, S.S., Robinson, S.M. & Wang, H.Y. (1981). Rapid determination of yeast viability. Biotechnology Bioengineering Symposia 11, 641-649.
19. Tiligada, E., Stavrinidis, E. & Delitheos, A. (1997). Effect of tamoxifen in lower eukaryotic cells. Anticancer Research 17, 4098.
20. Mariani, M., Prosperi, E., Colombo, A. & Supino, R. (1989). Doxorubicin resistance circumvention by verapamil in B19 melanoma cells. Anticancer Research 9, 29-32.
21. Tsuruo, T., Iida, H., Tsukagoshi, S. & Sakurai, Y. (1983). Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Research 43, 2267-2272.
22. Fojo, A.T. (1991). Multidrug resistance. Advances in Internal Medicine 36, 195-218.
23. Pratt, W.B., Ruddon, R.W., Ensminger, W.D. & Maybaum, J. (1994). The Anticancer Drugs, 2nd edn, 352pp. New York, USA: Oxford University Press.
24. Zwelling, L.A. (1989). Topoisomerase II as a target of antileukemia drugs: a review of controversial areas. Hematology and Pathology 3, 101-112.
25. Danks, M.K., Yalowich, J.C. & Beck, W.T. (1987). Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Research 47, 1297-1301.